Saxenda vs Mounjaro: Which Is Better for Weight Loss?

Last updated: October 29, 2026

Tirzepatide, the drug in Mounjaro, produced roughly three times the average weight loss seen with liraglutide, the drug in Saxenda, in head-to-head clinical trial data. That single fact drives most of the Saxenda vs Mounjaro: Which Is Better for Weight Loss? debate, but cost, side effects, dosing schedule, and your personal health history all matter just as much as the number on the scale.

I’ve spent years writing about GLP-1 medications, and the question I get most from readers isn’t “which drug is strongest.” It’s “which drug fits my life and my body without wrecking my budget or my stomach.” This article answers both versions of that question.

Quick Answer

Mounjaro (tirzepatide) generally produces greater weight loss than Saxenda (liraglutide) because it activates two gut hormone receptors instead of one [Source: NEJM, 2022]. Saxenda is a daily injection approved for chronic weight management and has a longer safety track record. Mounjaro is a weekly injection approved for type 2 diabetes, with tirzepatide also marketed as Zepbound specifically for weight loss. Your choice depends on efficacy needs, diabetes status, side effect tolerance, and price.

Key Takeaways

• Tirzepatide (Mounjaro’s active ingredient) produced higher average weight loss than liraglutide (Saxenda’s active ingredient) in published trial data [Source: NEJM, 2022].
• Saxenda requires a daily injection; Mounjaro is injected once weekly, which many people find easier to stick with.
• Saxenda is FDA- and EMA-approved for chronic weight management; Mounjaro’s FDA approval is for type 2 diabetes, while Zepbound (same drug, different brand) is approved for weight loss.
• Both drugs can cause nausea, vomiting, and diarrhea, but GI side effects are generally reported more often with tirzepatide at higher doses.
• Clinically meaningful weight loss is usually defined as losing at least 5 percent of body weight, with 10 percent or more considered a strong response.
• You should not combine Saxenda and Mounjaro, since both work on overlapping appetite pathways.
• Diet and activity changes are still required alongside either medication for the best results.

What’s the actual difference between Saxenda and Mounjaro?

Saxenda contains liraglutide, a GLP-1 receptor agonist, while Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. That second receptor target is the main reason Mounjaro tends to outperform Saxenda on the scale.

Liraglutide slows digestion and signals fullness to the brain through one hormone pathway [Source: Saxenda, how it works]. Tirzepatide does that plus mimics a second gut hormone, GIP, which appears to add extra appetite suppression and metabolic benefit [Source: NEJM, 2022]. Practically, this means:

• Saxenda: daily injection, one hormone pathway, longer approval history for weight management
• Mounjaro: weekly injection, two hormone pathways, newer to the weight-loss market under its own name

Choose Saxenda if you want a medication with a long-standing safety record for obesity treatment specifically. Choose Mounjaro (or its weight-loss twin, Zepbound) if maximum weight loss is your priority and you can tolerate a newer drug profile.

For a broader comparison beyond just these two, see our breakdown of which GLP-1 is best for weight loss across seven options.

How much does Saxenda cost with insurance?

Saxenda’s out-of-pocket cost with insurance varies widely depending on your plan’s formulary tier and whether your insurer covers anti-obesity medication at all. [VERIFY: current insurance coverage rates and copay amounts with your specific plan, as these change frequently].

Many insurance plans still classify weight-loss drugs differently than diabetes drugs, which affects coverage. Some plans require prior authorization showing a BMI above a certain threshold or a weight-related health condition. If your plan doesn’t cover Saxenda, the manufacturer has offered savings programs in the past [VERIFY: current savings card terms]. For readers on specific insurance plans, our guide on whether Kaiser covers GLP-1 medications for weight loss walks through one common scenario.

Mounjaro price per injection without insurance

Without insurance, Mounjaro typically costs several hundred dollars per month, and the price per single injection pen depends on the dose and pharmacy. [VERIFY: current list price, since manufacturer pricing and discount programs shift throughout the year].

A few things that affect what you’ll actually pay:

• Dose strength (higher doses often cost more)
• Whether you use a manufacturer savings card
• Pharmacy chain and location
• Whether you go through a telehealth provider with bundled pricing

If sticker shock is a concern, our detailed GLP-1 weight loss cost breakdown compares pricing structures across multiple drugs and provider types. You might also look into telehealth-based GLP-1 injection programs that sometimes offer more transparent pricing than retail pharmacies.

Which one works faster for weight loss, Saxenda or Mounjaro?

Mounjaro tends to produce noticeable weight loss faster and in larger amounts than Saxenda, based on comparative trial data. Most people on either drug see initial appetite changes within the first few weeks, but the depth of weight loss diverges over time.

In the SURMOUNT-1 trial, participants without diabetes lost substantially more weight on tirzepatide over roughly 72 weeks compared to what liraglutide studies have shown over similar timeframes [Source: Lilly SURMOUNT-1 results, NEJM]. Saxenda’s own trial data showed meaningful weight loss too, but at a slower pace and smaller overall magnitude [Source: Saxenda EPAR, EMA].

Decision rule: if you’ve plateaued on Saxenda after several months at the maximum tolerated dose, that’s a common reason people discuss switching to tirzepatide with their doctor.

Saxenda vs Mounjaro side effects comparison

Both drugs share similar gastrointestinal side effects, but the comparison table below can help you picture what to expect.

Side Effect	Saxenda (liraglutide)	Mounjaro (tirzepatide)
Nausea	Common	Common, dose-dependent
Diarrhea	Common	Common
Injection frequency	Daily	Weekly
Gallbladder issues	Reported	Reported
Pancreatitis risk	Boxed warning consideration	Monitored risk

Both drugs carry warnings related to thyroid C-cell tumors seen in rodent studies, and neither should be used by people with a personal or family history of medullary thyroid carcinoma [Source: FDA label, Saxenda; Source: FDA SPL data, tirzepatide].

Can you use Saxenda and Mounjaro at the same time?

No, you should not use Saxenda and Mounjaro together. Both drugs act on overlapping appetite and digestion pathways, so combining them increases the risk of severe nausea, vomiting, and dehydration without added benefit.

Doctors prescribe one GLP-1 or dual-agonist medication at a time. If Saxenda isn’t working well enough, the typical next step is tapering off it and transitioning to Mounjaro under medical supervision, not stacking the two.

Mounjaro for type 2 diabetes and weight loss

Mounjaro’s original and primary FDA approval is for improving blood sugar control in adults with type 2 diabetes, with weight loss as a well-documented secondary benefit. For weight loss specifically in people without diabetes, the same drug is sold under the brand name Zepbound.

Tirzepatide improves insulin sensitivity and reduces blood sugar spikes while also slowing stomach emptying, which contributes to both glucose control and appetite reduction [Source: Lilly SURPASS-class trial data referenced in SURMOUNT-2 results]. If you have type 2 diabetes and are overweight, Mounjaro addresses both conditions with one prescription, which is a real advantage over Saxenda in that specific situation.

Is Saxenda safe if you have heart problems?

Saxenda carries precautions for people with certain heart conditions, and you should discuss your full cardiac history with your doctor before starting. Liraglutide has been studied for cardiovascular safety, but individual risk factors like arrhythmia history still require case-by-case evaluation [Source: Saxenda EPAR, EMA].

People with a history of heart failure, uncontrolled high blood pressure, or arrhythmia should have a detailed conversation with a cardiologist or prescribing physician before starting either Saxenda or Mounjaro. Neither drug is automatically disqualifying for most stable heart conditions, but neither should be self-prescribed for someone with unmanaged cardiac issues.

How long before you see weight loss results on Mounjaro?

Most people on Mounjaro notice reduced appetite within the first two to four weeks, with measurable weight loss building over the following months. Substantial results, in the range seen in clinical trials, typically take 36 to 72 weeks of consistent use alongside dose escalation [Source: Lilly SURMOUNT-1 results, NEJM].

Weight loss isn’t linear. Expect faster drops early on, especially in the first three months, then a steadier, slower decline as your body adjusts. People who stop losing weight mid-treatment often haven’t reached their maximum tolerated dose yet, which is a common mistake worth discussing with your prescriber rather than assuming the drug “stopped working.”

What are the worst side effects of Saxenda?

The most serious potential side effects of Saxenda include pancreatitis, gallbladder disease, kidney problems from dehydration, and a boxed warning about thyroid C-cell tumors seen in animal studies. These are uncommon but require immediate medical attention if symptoms appear.

Warning signs to watch for:

• Severe, persistent abdominal pain (possible pancreatitis)
• Yellowing skin or eyes (possible gallbladder or liver issue)
• Signs of severe dehydration from persistent vomiting or diarrhea
• A lump or swelling in the neck, hoarseness, or difficulty swallowing (possible thyroid concern)

[Source: FDA label, Saxenda, 2023 update]. Call your doctor right away if any of these occur. Routine nausea and mild digestive upset are common and usually manageable, but the symptoms above are not routine.

Can you stop Saxenda and switch to Mounjaro?

Yes, many people switch from Saxenda to Mounjaro, usually because they’ve plateaued or want stronger results, but the switch should be done under medical guidance with a tapering and restart plan. There’s no fixed FDA-approved crossover protocol, so your prescriber will set the schedule based on your response and tolerance.

Typically this means stopping Saxenda, allowing a short washout period, then starting Mounjaro at its lowest dose and titrating upward just as a new patient would. Don’t assume you can start at a higher Mounjaro dose because you were already tolerating Saxenda; the two drugs work differently enough that dose tolerance doesn’t transfer directly.

Mounjaro and Saxenda: what are people not telling you

The biggest thing people leave out of online reviews is that weight regain is common after stopping either drug unless lasting lifestyle changes are in place. GLP-1 and dual-agonist medications treat appetite biology, not the underlying habits, so stopping the drug often brings appetite back too.

A few other things rarely mentioned in casual reviews:

• Muscle loss can accompany rapid weight loss on either drug if protein intake and resistance exercise aren’t prioritized.
• Insurance coverage gaps mean many people pay out of pocket for months before approval, if approval happens at all.
• Compounded versions of these drugs exist outside the standard pharmacy supply chain, and their quality and legal status vary by state [VERIFY: current compounding regulations in your state].
• Side effects often front-load in the first month after each dose increase, then ease, which can be mistaken for the drug “not working” right after a dose bump.

For a closer look at a related concern some patients report, see our article on whether Ozempic-class drugs cause hair loss and how to manage it, since similar patterns have been reported anecdotally with other GLP-1 medications.

Do you need to diet and exercise on Mounjaro?

Yes, diet and exercise remain necessary on Mounjaro for the best and most sustainable results. The drug reduces appetite and slows digestion, but it doesn’t replace the need for balanced nutrition and physical activity.

Clinical trials for tirzepatide paired the medication with a reduced-calorie diet and increased physical activity as part of the study protocol [Source: Lilly SURMOUNT-1 results, NEJM]. Skipping this part doesn’t block weight loss entirely, but it limits results and makes muscle preservation harder. Aim for adequate protein intake and some form of regular strength training to protect lean mass while the medication handles appetite control.

Other weight loss injections like Saxenda and Mounjaro

Saxenda and Mounjaro aren’t the only options. Wegovy (semaglutide), Zepbound (tirzepatide), Victoza (liraglutide for diabetes), and Trulicity (dulaglutide) are all related injectable medications with different approval scopes and efficacy profiles.

Here’s a general positioning, based on published trial efficacy data:

• Zepbound: same drug as Mounjaro, but branded and approved specifically for weight loss
• Wegovy: semaglutide-based, generally more effective than Saxenda but less than tirzepatide-based drugs in head-to-head efficacy data
• Victoza/Trulicity: primarily diabetes-focused, weight loss is secondary and smaller

If you’re exploring options beyond this comparison, our semaglutide weight loss injections guide and dosage chart for semaglutide cover that drug class in depth. If you’re not diabetic and wondering about eligibility generally, see our GLP-1 for weight loss guide for non-diabetics.

FAQ

Is Mounjaro always better than Saxenda for weight loss?
Not always. Mounjaro produces greater average weight loss in trial comparisons, but Saxenda may suit people who prefer a longer-established safety record or who respond poorly to tirzepatide’s side effects.

Can I get Mounjaro if I don’t have diabetes?
Mounjaro itself is FDA-approved for type 2 diabetes, but the identical drug (tirzepatide) is approved for weight loss under the brand name Zepbound. Ask your doctor which prescription pathway fits your situation.

How much weight can I realistically lose on Saxenda?
Clinically meaningful weight loss is generally defined as losing 5 percent or more of body weight, with some patients reaching 10 percent or more over months of treatment [Source: Saxenda EPAR, EMA].

Does insurance ever deny both drugs?
Yes, insurance denial is common for weight-loss indications specifically, even when diabetes indications are covered. [VERIFY: your specific plan’s current formulary status].

What happens if I miss a dose of Mounjaro?
Follow the specific guidance in the prescribing information for timing a missed weekly dose, and don’t double up doses without checking with your pharmacist or doctor.

Are compounded versions of these drugs safe?
Compounded tirzepatide and liraglutide exist outside standard manufacturing, and their quality, purity, and legal status vary. [VERIFY: current FDA and state-level guidance on compounded GLP-1 drugs before considering this route].

Can I switch back to Saxenda after trying Mounjaro?
Yes, that’s medically possible, though most people who switch to Mounjaro for stronger results don’t go back unless they experience side effects they can’t tolerate.

Conclusion

Mounjaro generally outperforms Saxenda for weight loss because it targets two appetite-related hormone pathways instead of one, but Saxenda remains a legitimate option with a longer approval history for chronic weight management. Your decision should weigh efficacy against cost, injection frequency, diabetes status, and your personal side effect tolerance. Neither drug works in isolation from diet and exercise, and switching between them should always happen under medical supervision rather than on your own schedule. If you’re still weighing your options, start by comparing providers and pricing through our GLP-1 cost comparison guide and bring your questions to a licensed healthcare provider before making a final choice.

This article is for informational purposes only and is not medical advice. Talk to a licensed healthcare provider before starting or changing any medication.

References

1. How IT Works. saxenda.com.
2. Saxenda Epar Product Information En. ema.europa.eu.
3. 206321s016lbl. accessdata.fda.gov.
4. Lillys Surmount 2 Results Published Lancet Show Tirzepatide. investor.lilly.com.
5. 7bb9293e 2a23 4662 9174 01468567657d. accessdata.fda.gov.
6. Lillys Surmount 1 Results Published New England Journal Medicine. investor.lilly.com.
7. Nejmoa2206038. nejm.org.